117 related articles for article (PubMed ID: 32064938)
1. Action plan for hit identification (APHID): KAT6A as a case study.
Yi X; Xue L; Thomas T; Baell JB
Future Med Chem; 2020 Mar; 12(5):423-437. PubMed ID: 32064938
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A.
Leaver DJ; Cleary B; Nguyen N; Priebbenow DL; Lagiakos HR; Sanchez J; Xue L; Huang F; Sun Y; Mujumdar P; Mudududdla R; Varghese S; Teguh S; Charman SA; White KL; Katneni K; Cuellar M; Strasser JM; Dahlin JL; Walters MA; Street IP; Monahan BJ; Jarman KE; Sabroux HJ; Falk H; Chung MC; Hermans SJ; Parker MW; Thomas T; Baell JB
J Med Chem; 2019 Aug; 62(15):7146-7159. PubMed ID: 31256587
[TBL] [Abstract][Full Text] [Related]
3. Targeting Histone Acetyltransferase MOZ/KAT6A as a New Avenue for Hematological Tumor Therapy.
Zhou C; Zhu HL; Duan Y
Curr Top Med Chem; 2020; 20(5):333-335. PubMed ID: 32242512
[No Abstract] [Full Text] [Related]
4. PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.
Dahlin JL; Nissink JW; Strasser JM; Francis S; Higgins L; Zhou H; Zhang Z; Walters MA
J Med Chem; 2015 Mar; 58(5):2091-113. PubMed ID: 25634295
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screening.
Zhang R; Wang J; Zhao L; Liu S; Du D; Ding H; Chen S; Yue L; Liu YC; Zhang C; Liu H; Luo C
Eur J Med Chem; 2018 Sep; 157():867-876. PubMed ID: 30145373
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Activity Assays for MYST Histone Acetyltransferases and Adaptation for High-Throughput Inhibitor Screening.
McCullough CE; Marmorstein R
Methods Enzymol; 2016; 573():139-60. PubMed ID: 27372752
[TBL] [Abstract][Full Text] [Related]
7. Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors.
Dahlin JL; Nelson KM; Strasser JM; Barsyte-Lovejoy D; Szewczyk MM; Organ S; Cuellar M; Singh G; Shrimp JH; Nguyen N; Meier JL; Arrowsmith CH; Brown PJ; Baell JB; Walters MA
Nat Commun; 2017 Nov; 8(1):1527. PubMed ID: 29142305
[TBL] [Abstract][Full Text] [Related]
8. MOZ/KAT6A: a promising target for acute myeloid leukemia therapy.
Zhou C; Liu W; Duan Y
Future Med Chem; 2020 May; 12(9):759-761. PubMed ID: 32212924
[No Abstract] [Full Text] [Related]
9. Acoustic Mist Ionization-Mass Spectrometry: A Comparison to Conventional High-Throughput Screening and Compound Profiling Platforms.
Belov AM; Kozole J; Bean MF; Machutta CA; Zhang G; Gao EN; Ghislain L; Datwani SS; Leveridge M; Annan RS
Anal Chem; 2020 Oct; 92(20):13847-13854. PubMed ID: 32970424
[TBL] [Abstract][Full Text] [Related]
10. Targeting cancer using KAT inhibitors to mimic lethal knockouts.
Brown JA; Bourke E; Eriksson LA; Kerin MJ
Biochem Soc Trans; 2016 Aug; 44(4):979-86. PubMed ID: 27528742
[TBL] [Abstract][Full Text] [Related]
11. Tip60: Main Functions and Its Inhibitors.
Zhang X; Wu J; Luan Y
Mini Rev Med Chem; 2017; 17(8):675-682. PubMed ID: 27670582
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer Agents.
Priebbenow DL; Leaver DJ; Nguyen N; Cleary B; Lagiakos HR; Sanchez J; Xue L; Huang F; Sun Y; Mujumdar P; Mudududdla R; Varghese S; Teguh S; Charman SA; White KL; Shackleford DM; Katneni K; Cuellar M; Strasser JM; Dahlin JL; Walters MA; Street IP; Monahan BJ; Jarman KE; Jousset Sabroux H; Falk H; Chung MC; Hermans SJ; Downer NL; Parker MW; Voss AK; Thomas T; Baell JB
J Med Chem; 2020 May; 63(9):4655-4684. PubMed ID: 32118427
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the activity of histone acetyltransferases by long chain alkylidenemalonates (LoCAMs).
Milite C; Castellano S; Benedetti R; Tosco A; Ciliberti C; Vicidomini C; Boully L; Franci G; Altucci L; Mai A; Sbardella G
Bioorg Med Chem; 2011 Jun; 19(12):3690-701. PubMed ID: 21292492
[TBL] [Abstract][Full Text] [Related]
14. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
[TBL] [Abstract][Full Text] [Related]
15. Post-HTS case report and structural alert: Promiscuous 4-aroyl-1,5-disubstituted-3-hydroxy-2H-pyrrol-2-one actives verified by ALARM NMR.
Dahlin JL; Nissink JWM; Francis S; Strasser JM; John K; Zhang Z; Walters MA
Bioorg Med Chem Lett; 2015 Nov; 25(21):4740-4752. PubMed ID: 26318992
[TBL] [Abstract][Full Text] [Related]
16. Histone acetyltransferase inhibitors: where art thou?
Baell JB; Miao W
Future Med Chem; 2016 Sep; 8(13):1525-8. PubMed ID: 27557114
[No Abstract] [Full Text] [Related]
17. A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylation.
Hardcastle A; Tomlin P; Norris C; Richards J; Cordwell M; Boxall K; Rowlands M; Jones K; Collins I; McDonald E; Workman P; Aherne W
Mol Cancer Ther; 2007 Mar; 6(3):1112-22. PubMed ID: 17363504
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth.
Baell JB; Leaver DJ; Hermans SJ; Kelly GL; Brennan MS; Downer NL; Nguyen N; Wichmann J; McRae HM; Yang Y; Cleary B; Lagiakos HR; Mieruszynski S; Pacini G; Vanyai HK; Bergamasco MI; May RE; Davey BK; Morgan KJ; Sealey AJ; Wang B; Zamudio N; Wilcox S; Garnham AL; Sheikh BN; Aubrey BJ; Doggett K; Chung MC; de Silva M; Bentley J; Pilling P; Hattarki M; Dolezal O; Dennis ML; Falk H; Ren B; Charman SA; White KL; Rautela J; Newbold A; Hawkins ED; Johnstone RW; Huntington ND; Peat TS; Heath JK; Strasser A; Parker MW; Smyth GK; Street IP; Monahan BJ; Voss AK; Thomas T
Nature; 2018 Aug; 560(7717):253-257. PubMed ID: 30069049
[TBL] [Abstract][Full Text] [Related]
19. An efficient high-throughput screening method for MYST family acetyltransferases, a new class of epigenetic drug targets.
Falk H; Connor T; Yang H; Loft KJ; Alcindor JL; Nikolakopoulos G; Surjadi RN; Bentley JD; Hattarki MK; Dolezal O; Murphy JM; Monahan BJ; Peat TS; Thomas T; Baell JB; Parisot JP; Street IP
J Biomol Screen; 2011 Dec; 16(10):1196-205. PubMed ID: 22086725
[TBL] [Abstract][Full Text] [Related]
20. Modeling Small-Molecule Reactivity Identifies Promiscuous Bioactive Compounds.
Matlock MK; Hughes TB; Dahlin JL; Swamidass SJ
J Chem Inf Model; 2018 Aug; 58(8):1483-1500. PubMed ID: 29990427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
